Gilead Sciences
Ad
related to: Ligand Pharmaceuticalssiemens.com has been visited by 10K+ users in the past month
Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. We Can Maintain an Environment that Helps You Do Your Best Work and Research.
- Contact us
Contact us for more information
about our products and services.
- Decarbonization
Learn how decarbonization will
shape the life sciences.
- Journey along a smart lab
Linking operational efficiency &
worker safety to stay ahead.
- Whistleblowing
Whistleblowing and Reporting
Channels. Learn More!
- Critical Environments
For professionals seeking detailed
information on laboratory systems.
- Scale up production
Smart life science technologies
can optimize your project timelines
- Contact us
Search results
Ligand is a healthcare investing company that provides technology and financing solutions to advance medicines. It owns royalties on commercial products and licenses its Captisol® platform to biopharmaceutical partners.
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to ...
Ligand invests in the clinical development and commercialization of high-value programs that can improve and extend lives. It also licenses its Captisol® technology platform to biopharmaceutical partners and generates royalties from its diversified portfolio of royalty assets.
Jun 27, 2024 · Ligand is a biopharmaceutical company that invests in and licenses high-value programs for various diseases. It also owns the Captisol® technology platform and generates royalty revenue from its portfolio of treatments.
Ligand Pharmaceuticals | 5,897 followers on LinkedIn. Ligand is a high-growth company with economic rights to some of the world's most important medicines. | Ligand is a biopharmaceutical...
Get the latest Ligand Pharmaceuticals Inc (LGND) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jan 5, 2024 · ZELSUVMI™ is expected to be commercially available during the second half of 2024 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMI™ (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum (molluscum) in adults and pediatric patients ...
